Related Experiment Video
Updated: Aug 6, 2025
08:06
Robotic Cochlear Implantation for Direct Cochlear Access
Published on: June 16, 2022
3.2K
Hospital-Negotiated Pricing of Cochlear Implants
Ryan A Bartholomew1, Vinay K Rathi1, Krish Suresh1
1Department of Otolaryngology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA.
Summary
Cochlear implant device prices vary significantly between manufacturers and hospitals, impacting accessibility. MED-EL devices were more expensive than Cochlear Ltd. devices, with substantial markups observed.
Area of Science:
- Health Economics
- Otolaryngology
- Medical Device Pricing
Background:
- Access to cochlear implantation (CI) is crucial for hearing restoration.
- Financial burdens and price variations in CI devices are not well understood.
- Understanding price disparities is essential for equitable healthcare access.
Purpose of the Study:
- To analyze the variation in private payer-negotiated prices for cochlear implant devices.
- To compare prices across different manufacturers and hospitals.
- To identify factors influencing cochlear implant device costs.
Main Methods:
- Cross-sectional analysis of private payer-negotiated prices for CI devices.
- Inclusion of data from 161 hospitals.
- Statistical comparison of prices between manufacturers (MED-EL vs. Cochlear Ltd.) and pricing strategies.
Main Results:
- Significant price variations were observed across hospitals and payers.
- MED-EL devices were priced higher ($38,478 ± $2633) than Cochlear Ltd. devices ($34,150 ± $2418).
- Cochlear Ltd. devices showed a mean markup of 58.5% over the average sales price; prices were lower when multiple brands were offered at a single center.
Conclusions:
- Substantial price differences exist for cochlear implant devices, independent of clinical outcomes.
- Manufacturer pricing strategies and hospital offerings influence device costs.
- Further research is needed on patient outcomes, hospital volume, and their impact on CI pricing.
